Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Change In Working Capital : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co Change In Working Capital?

Tonghua Dongbao Pharmaceutical Co's change in working capital for the quarter that ended in Mar. 2024 was ¥0 Mil.

Tonghua Dongbao Pharmaceutical Co's change in working capital for the fiscal year that ended in Dec. 2023 was ¥-442 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Tonghua Dongbao Pharmaceutical Co Change In Working Capital Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co Change In Working Capital Chart

Tonghua Dongbao Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

96.77

82.66

-2.56

72.56

-441.92

Tonghua Dongbao Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

Tonghua Dongbao Pharmaceutical Co Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Tonghua Dongbao Pharmaceutical Co Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Tonghua Dongbao Pharmaceutical Co's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Change In Working Capital

Traded in Other Exchanges

N/A

Address

Dongbao Village, Jilin Province, Tonghua, CHN, 134123

Website

http://www.thdb.com

Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.

Executives

Cheng Jian Qiu	Supervisors
Chang Xiao Hui	Director
Li Cong	Director
Li Feng Qin	Director
Chen Hong	senior management
Leng Chun Sheng	Director
Li Yi Kui	Director
Wang Dian Duo	Supervisors
Wang Jun Ye	Director
Han Jie	Director

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Headlines

No Headlines